Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
AgeX Therapeutics, Inc.
(AMEX:AGE)
$0.58
$-0.02
-3.98%
AgeX Therapeutics, Inc. Chart
AGE Stock Price Today
AgeX Therapeutics, Inc. (AGE) stock declined over -3.98% intraday to trade at $0.58 a share on AMEX. The stock opened with a loss of -3.33% at $0.6 and touched an intraday high of $0.609, falling -3.33% against the last close of $0.6. The stock went to a low of $0.568 during the session.
Stock Snapshot
$0.6
Prev. Close
23.19 Million
Market Cap
$0.568
Day Low
$0.6
Open
37.94 Million
Number of Shares
$0.609
Day High
-
P/E ratio
-0.24
EPS (TTM)
0.01
Cash Flow per Share
1.54
Free Float in %
-0.26
Book Value
29,271
Volume
AgeX Therapeutics, Inc. Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-06-30 | $0.6 | $0.609 | $0.568 | $0.576 | 29,271 |
| 2022-06-29 | $0.6 | $0.614 | $0.58 | $0.6 | 12,900 |
| 2022-06-28 | $0.59 | $0.6 | $0.57 | $0.58 | 5,800 |
| 2022-06-27 | $0.6 | $0.6 | $0.57 | $0.57 | 43,700 |
| 2022-06-24 | $0.6 | $0.64 | $0.574 | $0.574 | 52,000 |
| 2022-06-23 | $0.66 | $0.678 | $0.595 | $0.609 | 47,400 |
| 2022-06-22 | $0.6 | $0.658 | $0.6 | $0.658 | 9,600 |
| 2022-06-21 | $0.61 | $0.645 | $0.6 | $0.6 | 22,600 |
| 2022-06-17 | $0.625 | $0.664 | $0.61 | $0.62 | 24,700 |
| 2022-06-16 | $0.693 | $0.693 | $0.63 | $0.63 | 32,600 |
Contact Details
Company Information
Employees-
Beta1.41
Sales or Revenue144 Thousands
5Y Sales Change-38.70%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
About Company
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.
Frequently Asked Questions
What is the current AgeX Therapeutics, Inc. (AGE) stock price?
AgeX Therapeutics, Inc. (AMEX: AGE) stock price is $0.58 as of the last check on Thursday, June 30. During the trading session, AGE stock reached the peak price of $0.609 while $0.568 was the lowest point it dropped to.
AGE's industry and sector of operation?
The AMEX listed AGE is part of Biotechnology industry that operates in the broader Health Care sector. AgeX Therapeutics, Inc. , a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States.
Who are the executives of AGE?
Dr. Michael D. West Ph.D.
Founder, Pres, CEO & Director
Ms. Eun-Jae Park CPA
Chief Financial Officer
Dr. Nafees Naseer Malik M.D.
Chief Operating Officer
Dr. Ivan Labat
Chief Information Officer
What is the AGE stock price today?
AGE stock traded closed the last session at $0.576, which is $-0.02 or -3.98% lower than its previous close of $0.6. AGE's current trading price is 11.62% lower than its 52-week high of $1.71 where as its distance from 52-week low of 0.52% is -66.30%.
How many employees does AGE have?
Number of AGE employees currently stands at -. AGE operates from 1101 Marina Village Parkway, Suite 201, Alameda, CA 94501, United States.
Link for AGE official website?
Official Webiste of $AGE is: https://www.agexinc.com
How do I contact AGE?
AGE could be contacted at AGE operates from 1101 Marina Village Parkway, Suite 201, Alameda, CA 94501, United States, or at phone #510 671 8370 and can also be accessed through its website.
How many shares of AGE are traded daily?
AGE stock volume for the day was 29,271 shares while in the previous session number of AGE shares traded was 29,271 . The average number of AGE shares traded daily for last 3 months was 44.83 Thousands.
How much did AGE change today?
The percentage change in AGE stock occurred in the recent session was -3.98% while the dollar amount for the price change in AGE stock was $-0.02.
What price range AGE stock been trading in?
In the recent session, the day high for AGE stock was $0.609 while the low for AGE stock touched on the day was $0.568.
What is the market cap of AGE currently?
The market value of AGE currently stands at 23.19 Million with its latest stock price at $0.58 and 37.94 Million of its shares outstanding.